Baker Brothers Advisors - AEROVATE THERAPEUTICS INC ownership

AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 57 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AEROVATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,644,410
-20.9%
1,963,4790.0%0.15%
-21.0%
Q2 2023$33,673,665
-15.0%
1,963,4790.0%0.20%
-9.3%
Q1 2023$39,603,371
-31.6%
1,963,479
-0.7%
0.22%
-38.2%
Q4 2022$57,922,232
+76.5%
1,976,868
-0.1%
0.35%
+61.9%
Q3 2022$32,821,000
+1.4%
1,979,568
-4.4%
0.22%
+16.8%
Q2 2022$32,354,000
-14.7%
2,070,0100.0%0.18%
-15.6%
Q1 2022$37,943,000
+75.7%
2,070,010
+13.0%
0.22%
+107.6%
Q4 2021$21,597,000
-37.7%
1,831,789
+10.9%
0.10%
-30.9%
Q3 2021$34,663,000
+6.3%
1,652,171
+15.7%
0.15%
+6.3%
Q2 2021$32,614,0001,428,5710.14%
Other shareholders
AEROVATE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 603,762$8,193,05018.42%
TCG Crossover Management, LLC 2,201,274$29,871,2884.40%
Atlas Venture Life Science Advisors, LLC 2,039,249$27,672,6094.29%
Sofinnova Investments, Inc. 3,758,686$51,005,3693.22%
GREAT POINT PARTNERS LLC 1,091,233$14,808,0322.70%
RA Capital Management 8,263,982$112,142,2362.21%
Cormorant Asset Management, LP 1,561,696$21,192,2151.24%
Frazier Life Sciences Management, L.P. 1,204,867$16,350,0451.09%
Octagon Capital Advisors LP 497,370$6,749,3111.04%
Ghost Tree Capital, LLC 201,197$2,730,2430.90%
View complete list of AEROVATE THERAPEUTICS INC shareholders